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Objectives This study sought to report percutaneous coronary intervention (PCI) 30-day readmis-
sion rates, identify the impact of staged (planned) readmissions on overall readmission rates, deter-
mine the signiﬁcant predictors of unstaged readmissions after PCI, and specify the reasons for
readmissions.
Background Hospital readmissions occur frequently and incur substantial costs. PCI are among the
ost common and costly procedures, and little is known about the nature and extent of readmis-
ions for PCI.
ethods We retrospectively analyzed 30-day readmissions after PCI using the nation’s largest state-
ide PCI registry to identify 40,093 New York State patients who underwent PCI between January 1,
007, and November 30, 2007. Demographic variables, pre-procedural risk factors, complications of
CI, and length of stay were considered as potential predictors of readmission, and reasons for read-
ission were identiﬁed from New York’s administrative database using principal diagnoses.
esults A total of 15.6% of all PCI patients were readmitted within 30 days, and 20.6% of these
eadmissions were staged. Among unstaged readmissions, the most common reasons for readmis-
ion were chronic ischemic heart disease (22.5%), chest pain (10.8%), and heart failure (8.2%). A total
f 2,015 patients (32.2% of readmissions) underwent a repeat PCI. Thirteen demographic and diag-
nostic risk factors, as well as longer lengths of stay, were all associated with higher readmission rates.
Conclusions Future efforts to reduce readmissions should be directed toward the recognition of
patients most at risk, and the reasons they are readmitted. Staging also should be examined from a
cost-effectiveness standpoint as a function of patients’ unique risk factors. (J Am Coll Cardiol Intv
2011;4:1335–42) © 2011 by the American College of Cardiology Foundation
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1336Short-term hospital readmissions account for a substantial
portion of our country’s healthcare budget. For example,
Jencks et al. (1) found that 1 in every 5 Medicare fee-for-
ervice beneficiaries hospitalized between 2003 and 2004
as readmitted within 30 days. In 2004, the estimated cost
f these unplanned 30-day hospital readmissions was $17.4
illion, which comprised nearly 17% of all the hospital
ayments made by Medicare in that year. A study that
eviewed recent literature on readmissions found that be-
ween 9% and 48% of all readmissions were judged to be
reventable because “they were associated with indicators of
ubstandard care during the index hospitalization such as
oor resolution of the main problem, unstable therapy at
ischarge, and inadequate post-discharge care” (2).
See page 1343
One of the challenges in reducing short-term readmis-
sions is that large studies of representative populations have
generally lacked detailed infor-
mation about the index popula-
tion and the subsequent admis-
sion. However, the New York
Percutaneous Coronary Inter-
ventions Reporting System
(PCIRS) does contain this de-
tailed information, including the
ability to determine which PCI
patients were staged to undergo
another PCI on a diseased vessel
not attempted during the index
admission. PCIRS also has the
ability to link patients across ad-
missions so that detailed clinical
data are available about the patient
if a repeat PCI is performed. If the patient is readmitted without
a subsequent PCI, New York’s administrative data are available to
determine the primary reason for readmission.
The purposes of this study are to report PCI readmission
rates, identify the impact of staged (planned) readmissions on
overall readmission rates, determine the significant predictors
of unstaged 30-day readmissions after PCI, and specify the
reasons for readmissions. It is expected that with better
information about which patients are at higher risk for read-
mission following PCI and why they are readmitted, effective
efforts can be undertaken to reduce readmission rates. Further-
more, information never reported in earlier studies about the
extent of staging for PCI can aid in efforts to examine the
advisability of staging and to reduce overall readmission rates.
Methods
Data. The main database used in this study was the New
Abbreviations
and Acronyms
AMI  acute myocardial
nfarction
ABG  coronary artery
ypass graft
CI  percutaneous
oronary intervention
CIRS  Percutaneous
oronary Interventions
eporting System
PARCS  Statewide
lanning and Research
ooperative SystemYork State PCIRS registry, which was developed in 1991for the purpose of collecting information on all patients
undergoing PCI in New York’s nonfederal hospitals.
PCIRS contains detailed information for each patient un-
dergoing PCI in the state regarding demographics; pre-
procedural risk factors; peri-procedural complications; types
of devices used; extent of disease and lesions treated; dates
of admission, discharge, and procedure; discharge disposi-
tion and destination; and hospital and operator identifiers.
The data are collected by hospital catheterization laborato-
ries, entered on paper forms, and then submitted to the New
York State Department of Health on diskettes or through a
web-based submission process. The data are checked for
accuracy and completeness by matching to administrative
data and by extensive auditing of medical records by the
New York State Department of Health’s utilization review
agent. Between one-quarter and one-third of the hospitals
are audited each year on the basis of the accuracy of previous
reporting, the time elapsed since the previous audit, and
reported risk factor prevalence rates.
New York’s Statewide Planning and Research Coopera-
tive System (SPARCS) is New York’s administrative dis-
charge database. It includes information on demographics,
diagnoses, procedures, admission and discharge dates, and
discharge destination. SPARCS was used to identify read-
missions to a hospital within 30 days after discharge from an
index admission, and then these readmissions were matched
to PCIRS to identify PCI patients who were readmitted
within 30 days. For patients who were readmitted within 30
days who did not undergo repeat PCI, SPARCS was used
to identify the primary reason for readmission (principal
diagnosis). Data on patients who underwent subsequent
PCI in their readmission were obtained from PCIRS
because it contains more comprehensive information. New
York’s vital statistics data were used to identify deaths that
occurred within 30 days after discharge from the hospital.
Figure 1 provides a flow chart of how datasets were combined for
use in the analyses.
Study group and endpoints. The focus of the study was all
ew York State patients undergoing PCI between January
, 2007, and November 30, 2007 (the most recently audited
ata in the state) that resulted in live discharges. These
atients were followed after discharge to determine whether
hey died or were readmitted to the hospital within 30 days
fter discharge from the index PCI. Initially, there were
6,699 PCI procedures performed. We excluded those that
ere performed on patients who had a previous PCI within
0 days (n  2,662), had coronary artery bypass graft
CABG) surgery before PCI in the same admission (n 
4), were transferred to another acute care facility (n 
12), died during the index hospitalization (n  291), and
were not New York State residents (n  1,809). After then
removing 1,608 patients whose medical records could not be
found in administrative data, the study group included
40,093 PCIs performed on 37,234 patients. The study was
TVPCI
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 , N O . 1 2 , 2 0 1 1 Hannan et al.
D E C E M B E R 2 0 1 1 : 1 3 3 5 – 4 2 30-Day Readmissions for Patients Undergoing PCI
1337limited to New York State residents to minimize the chance
that unknown out-of-state readmissions occurred. A total of
52 hospitals (all hospitals in which PCI was performed
during the study period) were included in the study.
A subgroup of special interest was the group of patients
who were staged (planned) to undergo PCI within 30 days
of being discharged after the index admission.
Staged readmissions are defined as readmissions that were
planned in the index admission (as evidenced by coding a
data element in the index admission indicating the intention
to perform PCI in a future admission for a diseased coronary
Figure 1. Flow Chart of Data in Analysis Process
Flow chart for identiﬁcation of patients in various subanalyses. PCI  percutan
ing System; SPARCS  Statewide Planning and Research Cooperative System;vessel not attempted during the index admission). Also,there has to be evidence that the patient underwent a
subsequent PCI in a nontarget lesion within 30 days of the
index procedure. If patients who were initially indicated as
“staged” were readmitted unexpectedly for target lesion
revascularization, these patients were not regarded as staged
regardless of the initial plan.
The primary endpoint in the study was the 30-day
readmission rate. Thirty-day after-discharge mortality rates
were also obtained using New York vital statistics data.
Statistical analysis. Readmissions were classified by age
(65 and 65 years) and acute myocardial infarction
coronary intervention; PCIRS  Percutaneous Coronary Interventions Report-
 target vessel percutaneous coronary intervention.eous(AMI) status in the index PCI. The chi-square test was
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1338used to test for the differences in the proportions of
readmissions among patients over and under age 65 years,
and among AMI and non-AMI patients. Reasons for
unstaged readmissions were then examined. Target vessel
PCI (the need for re-intervention in the vessel chosen for
the index procedure) was considered a reason regardless of
the patient’s principal diagnosis. For unstaged patients not
undergoing target vessel PCI, the reason for readmission
was defined to be the principal diagnosis of the patient in
SPARCS, which was represented by an ICD-9-CM (In-
ternational Classification of Diseases-9th Revision-Clinical
Modification) code.
The independent relationship between unstaged read-
missions within 30 days after discharge and a wide variety
of potential risk factors (demographic, ventricular func-
tion, vessels diseased, previous myocardial infarction,
previous interventions, a large number of comorbidities,
complications of PCI that occurred during the index
admission, length of stay) was examined by developing a
stepwise logistic regression model with readmissions (yes,
no) as the binary dependent variable. All significant
independent predictors were then entered into a logistic
regression model with generalized estimating equations
to account for clustering of patients within hospitals (3).
The purpose of this analysis was to enable hospitals and
physicians to identify patients who are at the highest risk
of readmission so that those patients can be monitored
more closely.
All tests were conducted at the 0.05 level, all confidence
limits were 2-sided, and all analyses were conducted in SAS
version 9.1 (SAS Institute, Cary, North Carolina).
Results
The all-cause 30-day readmission rate was 15.6%, the
staged readmission rate was 3.2% of all patients (and 20.6%
of all readmissions), and the readmission rate for unstaged
patients was 12.4%. The variation across hospitals in the
percentage of PCI patients staged for a subsequent PCI
ranged from 0% to 8% among hospitals with at least 50
PCIs. A total of 863 of the 6,254 readmissions (13.8%) were
patients who suffered an AMI within 24 h before undergo-
ing PCI in the index admission. Also, 17.3% (863 of 4,993)
of the AMI patients were readmitted, compared with 15.4%
of all patients without AMI (p  0.0005). Of the patients
age 65 years and older, 17.2% were readmitted, compared
with 13.9% of the patients under age 65 years (p  0.0001)
(Table 1).
With regard to all patients readmitted for other than a
staged procedure (Table 2), 250 (5.0%) underwent a target
vessel PCI during their readmission. Among patients with-
out target vessel PCI, the most common cardiac-related
reasons for readmission were chronic ischemic heart disease
(22.9%), chest pain (11.1%), heart failure (7.6%), arrhyth-mias (4.4%), and AMI (2.9%). For patients readmitted for
noncardiac reasons, the most common principal diagnoses
were complications as a result of a previous procedure/
medical care (6.7% of unstaged patients), digestive system
(6.0%), circulatory system other than cardiac (5.7%), and
respiratory system (4.9%). Table 2 also presents reasons for
readmission according to whether patients experienced an
AMI before the index admission.
A total of 2,015 (32.2%) of the patients readmitted
within 30 days underwent a repeat PCI (staged or
otherwise) during the readmission, and 1.3% of the
readmissions underwent CABG surgery during the read-
mission (not shown). Of these repeat PCIs, 730 (36.2%)
were unstaged and 1,285 (63.8%) were staged. Overall, 4
deaths (0.3%) occurred among staged readmissions, and
the mortality rate for unstaged readmissions was 1.8%
(0.7% for patients undergoing PCI and 2.0% for other
patients, p  0.0001). A total of 95.5% of staged
readmissions were to the hospital of the index admission,
whereas only 58.8% of unstaged readmissions were to the
same hospital (89.5% when the unstaged readmission was
for PCI, and 53.5% when a PCI was not performed in the
unstaged readmission).
Table 3 presents the significant predictors of unstaged
readmissions within 30 days. As indicated, the number of
years over age 65, females, low ejection fraction, multivessel
disease, AMI within 1 to 14 days, peripheral vascular
disease, malignant ventricular arrhythmia, chronic obstruc-
tive pulmonary disease, diabetes, and renal failure were all
associated with higher readmission rates. Also, having a
post-PCI stroke, renal failure following PCI, and longer
lengths of stay in the index admission were all associated
with higher rates of readmission.
Discussion
A key procedure to examine for hospital readmissions is
Table 1. Staged and Unstaged Readmissions
Variable
Number of Readmissions
(Readmission Rate in Percentage)
p Value
AMI
(n  4,993)
No AMI
(n  35,100) Total
Age 65 yrs (n  19,289) 509 2,175 2,684 (13.9) 0.0001*
Age 65 yrs (n  20,804) 354 3,216 3,570 (17.2)
Total 863 (17.3) 5,391 (15.4) 6,254 (15.6)
p Value 0.0005†
Values are for readmissions within 30 days after PCI among patients with or without AMI in the
index PCI: New York, between January 1, 2007, and November 30, 2007. *p Value from chi-square
test for comparing the proportion of readmissions between patients younger than age 65 years
and those 65 or older. †p Value from chi-square test for comparing the proportion of readmis-
sions between patients with AMI and those without AMI in the index PCI.
AMI acute myocardial infarction; PCI percutaneous coronary intervention.PCI because it is one of the most common procedures
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1339performed in the United States, with 622,000 procedures
performed in 2007, and because of its cost ($48,399 mean
charges per patient in 2006) (4). Coronary stent placement
ccounts for 1.6% of all Medicare readmissions, and it is
eing considered for public reporting by the Centers for
edicare and Medicaid Services (1).
Despite these compelling reasons to study readmissions
for PCI, we have found only a single study in the literature
on readmissions for PCI. Curtis et al. (5) used Medicare
laims data from 2005 to identify the percentages of
ll-cause 30-day readmissions for all PCI patients older than
5 years, as well as for AMI and non-AMI patients who
nderwent PCI. They found an all-cause readmission
ate of 14.6%, with 17.5% for AMI patients and 13.6%
or non-AMI patients. Also, 25.8% of the readmissions
Table 2. Principal Diagnosis (Reason for Readmissio
Principal Diagnosis of
Unstaged Readmissions AMI in Inde
Target vessel PCI 51 (7.13
Readmission without target vessel PCI
Cardiac
Chronic ischemic heart disease 142 (19.8
Chest pain 66 (9.23
Heart failure 83 (11.6
Arrhythmias 28 (3.92
Myocardial infarction 47 (6.57
Atherosclerosis 1 (0.14
Other cardiac diseases* 21 (2.94
Noncardiac
Complication as a result of previous
procedure/medical care
62 (8.67
Digestive system 45 (6.29
Circulatory system, except cardiac 43 (6.01
Respiratory system 24 (3.36
Endocrine, nutritional, and metabolic 11 (1.54
Kidney and urinary tract 12 (1.68
Infectious and parasitic diseases 9 (1.26
Musculoskeletal system and connective
tissue
10 (1.40
Cancer 2 (0.28
Injuries, poison and toxic effect of drugs 10 (1.34
Skin, subcutaneous tissue and breast 4 (0.56
Blood and blood-forming organs and
immunologic disorders
8 (1.12
Other noncardiac diseases† 36 (5.03
Total 715
Values are n (%). Values are for unstaged readmissions within 30 days
between January 1, 2007, and November 30, 2007. *Includes other a
aortic aneurysm and dissection, acute pericarditis, angina pectoris,
endocardium, other aneurysm, cardiomyopathy, and ill-defined descri
system and pancreas, mental diseases and disorders, diseases of n
childbirth and puerperium, diseases of reproductive system, diseases
Abbreviations as in Table 1.nderwent PCI and 1.7% underwent CABG surgery (5). ewo similar studies that identified causes for readmission
ollowing CABG surgery have also been published (6,7).
The New York State PCIRS is especially well suited to
xamine readmissions for PCI. Unlike other available
atabases, it can identify which PCI patients were staged
o undergo a subsequent PCI, so that these patients can
e separated from other PCI patients when examining
auses of readmissions and policies for reducing readmis-
ions.
Also, unlike the American College of Cardiology’s Na-
ional Cardiac Data Registry, New York’s PCIRS can link
atients across readmissions to multiple hospitals so that
easons for and predictors of readmissions can be explored,
nd PCIRS is population based (not restricted to a select
roup of participating hospitals). Unlike Medicare data, it can
N (Column Percentage)
No AMI in Index PCI Total Chi-Square p Value
199 (4.68) 250 (5.03) 0.006
974 (22.90) 1,116 (22.46) 0.07
470 (11.05) 536 (10.79) 0.15
323 (7.59) 406 (8.17) 0.0003
187 (4.40) 215 (4.33) 0.56
124 (2.91) 171 (3.44) 0.0001
84 (1.97) 85 (1.71) 0.0005
83 (1.95) 104 (2.09) 0.09
285 (6.70) 347 (6.98) 0.06
257 (6.04) 302 (6.08) 0.79
242 (5.69) 285 (5.74) 0.73
209 (4.91) 233 (4.69) 0.07
126 (2.96) 137 (2.76) 0.03
105 (2.47) 117 (2.35) 0.20
70 (1.65) 79 (1.59) 0.44
49 (1.15) 60 (1.21) 0.61
57 (1.34) 59 (1.19) 0.02
49 (1.14) 59 (1.17) 0.57
48 (1.13) 52 (1.05) 0.17
43 (1.01) 51 (1.03) 0.79
269 (6.32) 305 (6.14) 0.18
4,254 4,969
I among patients with or without acute MI in the index PCI: New York,
d subacute forms of ischemic heart disease, diseases of pericardium,
tion disorders, acute and subacute endocarditis, other diseases of
nd complications of heart disease. †Include diseases of hepatobiliary
system, alcohol/drug use or induced mental disorders, pregnancy,
ar, nose, mouth, and throat, and ungroupable diseases.n)
x PCI
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1340because the cost to society of readmissions accrues for all
patients, and estimating this burden by extrapolating read-
missions for Medicare patients can be misleading. Further-
more, PCIRS contains clinical data elements not in Medi-
care databases for purposes of identifying predictors of
readmission.
In our study consisting of PCI patients of all ages in
Table 3. Significant Independent Predictors of Unsta
New York, between January 1, 2007, and November
Predictors Prevalence (
Demographic
Age 65 yrs —
Female 33.01
Black 10.89
Pre-operative risk factors
Ejection fraction
40% 88.71
20% 0.73
20%–29% 3.23
30%–39% 7.33
Number of diseased vessels
3 86.09
3 13.91
Pre-procedural MI
14 days or no MI 82.38
6 h 1.97
6–23 h† 2.74
1–14 days 12.91
Peripheral vascular disease 7.38
Malignant ventricular arrhythmia 0.51
COPD 6.14
Diabetes 33.02
Renal failure
Creatinine 1.5 mg/dl 89.82
Creatinine 1.6–3.0 mg/dl 5.85
Creatinine 3.0 mg/dl 0.54
Requiring dialysis 1.96
In-hospital post-procedural complications
Stroke 0.13
Renal failure 0.08
Other factors
Length of stay after index PCI
1 day 69.36
2 days 12.19
3 days 6.96
4 days 11.49
*All odds ratios andpvalues are froma stepwise logistic regressionuse
significant in thegeneralizedestimatingequationmodel after adjustin
main disease, hemodynamic instability, shock, congestive heart failu
Q-waveMI, acute occlusion in the target vessel, acute occlusion in a sig
6 to 23 h was forced into the model. C 0.64 Hosmer–Lemeshow chi-
COPD chronic obstructive pulmonary disease; OR odds ratio; PNew York State, we found an all-cause readmission rateof 15.6%. The staged readmission rate was 3.2%, and the
unstaged readmission rate was 12.4% (20.6% of all
readmissions were staged). There was a 17.3% overall
readmission rate for patients presenting at the index
admission with AMI and a 15.3% rate for patients
presenting without AMI. A total of 32.2% of the read-
missions underwent PCI, and 1.3% underwent CABG
eadmissions Within 30 Days After PCI:
007
Estimate OR
95% CI
p Value*Lower Upper
0.0149 1.02 1.01 1.02 0.0001
0.2795 1.32 1.25 1.40 0.0001
0.0581 1.06 0.96 1.17 0.24
1.00 — —
0.7307 2.08 1.62 2.66 0.0001
0.2727 1.31 1.13 1.53 0.0004
0.1833 1.20 1.07 1.35 0.002
1.00 — —
0.1090 1.12 1.01 1.23 0.03
1.00 — —
0.1562 0.86 0.75 0.98 0.02
0.0028 1.00 0.87 1.15 0.97
0.1442 1.16 1.05 1.27 0.003
0.3574 1.43 1.29 1.59 0.0001
0.4058 1.50 1.03 2.18 0.03
0.4688 1.60 1.44 1.77 0.0001
0.1902 1.21 1.13 1.30 0.0001
1.00 — —
0.2148 1.24 1.12 1.37 0.0001
0.6658 1.95 1.33 2.86 0.0007
0.6054 1.83 1.54 2.18 0.0001
1.0511 2.86 1.50 5.47 0.002
0.8647 2.37 1.21 4.65 0.01
1.00 — —
0.2958 1.34 1.22 1.49 0.0001
0.5146 1.67 1.47 1.91 0.0001
0.8111 2.25 2.00 2.54 0.0001
adjustmentwith significance level 0.05, but somemight beno longer
hin-hospital correlation. Additional candidates for themodelwere left
same admission, and the following post-procedural complications:
side branch, arterial or venous injury, emergency cardiac surgery.†MI
statistic for goodness of fit 10.16, p 0.25.
rcutaneous coronary intervention.ged R
30, 2
%)
d for risk
g forwit
re in the
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squaresurgery in the readmission.
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1341We also found that patients under age 65 years were
somewhat less likely to be readmitted than the group of
older patients in the Curtis et al. (5) study, but that our
comparable group of patients older than 65 were more likely
to be readmitted. For patients under 65, we found a
readmission rate of 13.9%, compared with 17.2% for pa-
tients 65 years and older (and compared with 14.6% for
Medicare patients reported by Curtis et al. [5]).
Numerous pre-procedural patient risk factors, 2 compli-
cations (stroke and renal failure following PCI), and long
length of stay were all related to higher readmission rates.
This is valuable information because it can be used to alert
hospitals to be particularly cautious with treatment and
discharge policies for patients with specific comorbidities,
and can be used to target outpatient follow-up of patients at
high risk for readmission.
We were also able to subdivide readmissions on the basis
of whether or not patients were readmitted electively for
staged PCI. We found that 20.6% of all 30-day readmis-
sions were staged readmissions whereby some diseased
coronary vessels are treated in a subsequent readmission
because it is deemed wise to treat only the culprit vessel
during the index admission. This is important information
because staged readmissions, although they may not always
be advisable or in the best interest of patients, are certainly
different from readmissions for complications of the index
PCI, and should not be regarded as adverse outcomes, as
noted by Bove and Spertus (8). It is also true that multi-
vessel revascularization during the index procedure or later
during the index revascularization may sometimes be asso-
ciated with better outcomes, although this strategy is clearly
not appropriate for all patients, particularly acute AMI
patients (9–11). However, if staged procedures were re-
garded as adverse outcomes from the standpoint of denying
payment, this might simply result in staged procedures with
a further delay between treatment episodes.
For readmitted patients who are not staged, our results
demonstrate that there is a wide variety of reasons for read-
mission. Target vessel PCI is clearly a complication of the
index procedure, and arguably most principal diagnoses that
are cardiac-related indicate problems either resulting from or
not remedied by the index procedure. A caveat of the study is
that it is not always possible to discern when patients were
readmitted for complications of the index PCI as opposed to
unrelated problems. Noncardiac principal diagnoses may be a
complication of the procedure (e.g., an ICD-9-CM code for
“complication due to previous procedure”), may be unrelated to
the procedure (cancer, or mental diseases), or it may be unclear
whether there is a relationship.
It is also notable that 42% of all unstaged readmissions
within 30 days occurred within 1 week. This suggests that
keeping patients in the hospital longer during the index
admission may have been effective in decreasing the read-
mission rate. A consensus document by Chambers et al. (12)recommends which patients can receive PCI as outpatients,
which patients require a 1-day inpatient stay, and which
patients require longer stays. These criteria could be bene-
ficial in identifying patients who could have avoided read-
mission by having a longer index admission and could also
be used to save resources by identifying patients who do not
need an in-patient stay.
A caveat of the study is that administrative data were the
only data available for determining reasons for readmission.
Although we are not aware of other databases that have any
better information, this is unfortunate because principal
diagnoses, such as “chronic ischemic heart disease,” “ath-
erosclerosis,” and “chest pain” are not specific enough to
determine the real reason for readmission, and leave some
doubt as to whether the readmission was necessitated by a
complication of the index procedure. Since “chronic isch-
emic heart disease” is coded for so many readmissions, we
recommend future studies to review all records with this
administrative code to determine the real reason for admis-
sion. Nevertheless, we believe our study is the first one to
examine PCI readmissions with access to clinical data for
index admissions and readmissions involving repeat revas-
cularization, as well as the first study to report staged
readmissions
Conclusions
This study has documented that readmission rates for PCI
are quite high, and that most readmissions are not for staged
procedures. For staged patients, possible strategies for de-
creasing readmissions for PCI include increasing the use of
multivessel revascularization during the index admission in
lieu of staging. However, the cost effectiveness of this option
is dependent on patients’ specific characteristics/risk factors.
Although, as noted in the previous text, some work has been
done in this area (9–11), much more needs to be done,
articularly with regard to elective (no recent AMI) patients
nd with regard to cost.
For unstaged patients, possible strategies include reduc-
ng complication rates and intensifying outpatient follow-up
f patients at highest risk of readmission. Our study is also
he first study to identify clinical predictors of readmissions
n this population. This knowledge is critical in efforts to
educe future admissions by targeting patients most in need
f monitoring for outpatient follow-up.4,5
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